| Literature DB >> 35332250 |
Sang Hun Eum1, Hanbi Lee1, Eun Jeong Ko1,2, Hyuk Jin Cho3, Chul Woo Yang1,2, Byung Ha Chung4,5.
Abstract
Computed tomography (CT) and nuclear renography are used to determine kidney procurement in living kidney donors (LKDs). The present study investigated which modality better predicts kidney function after donation. This study included 835 LKDs and they were divided into two subgroups based on whether the left-right dominance of kidney volume was concordant with kidney function (concordant group) or not (discordant group). The predictive value for post-donation kidney function between the two imaging modalities was compared at 1 month, 6 months, and > 1 year in total cohort, concordant, and discordant groups. Split kidney function (SKF) measured by both modalities showed significant correlation with each other at baseline. SKFs of remaining kidney measured using both modalities before donation showed significant correlation with eGFR (estimated glomerular filtration rate) after donation in the total cohort group and two subgroups, respectively. CT volumetry was superior to nuclear renography for predicting post-donation kidney function in the total cohort group and both subgroups. In the discordant subgroup, a higher tendency of kidney function recovery was observed when kidney procurement was determined based on CT volumetry. In conclusion, CT volumetry is preferred when determining procurement strategy especially when discordance is found between the two imaging modalities.Entities:
Mesh:
Year: 2022 PMID: 35332250 PMCID: PMC8948196 DOI: 10.1038/s41598-022-09187-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic and clinical characteristics of the donors.
| Number of studied donors | 835 | ||
| Age at kidney donation (years) | 43.76 ± 12.07 | ||
| Sex (female) | 471 (56.41) | ||
| BMI (kg/m2) | 23.91 ± 3.23 | ||
| Living donor type (related) | 513 (61.44) | ||
| Donated kidney (Lt.) | 701 (83.96) | ||
| Remaining kidney volume/BSA (cm3/m2) | 101.68 ± 15.56 | ||
| Remaining kidney mGFR/BSA (mL/min/m2) | 32.35 ± 5.49 | ||
| Baseline serum creatinine (mg/dL) | 0.81 ± 0.16 | ||
| eGFR (CKD-EPI) (mL/min/1.73m2) | 100.01 ± 13.94 | ||
| mGFR (Plasma method DTPA) (mL/min) | 107.16 ± 17.39 | ||
Values are mean ± standard deviation or frequency (%).
BMI body mass index, DTPA diethylenetriamine penta-acetic acid, GFR glomerular filtration rate, eGFR estimated glomerular filtration rate, mGFR measured glomerular filtration rate.
Demographic and Clinical Characteristics comparison between (a) concordant and discordant groups, (b) CT volumetry preferred and nuclear renography preferred groups.
| (a) | Concordant group (n = 509) | Discordant group (n = 326) | P value |
|---|---|---|---|
| Remaining kidney volume/BSA (cm3/m2) | 102.11 ± 16.02 | 101.01 ± 14.82 | 0.320 |
| Remaining kidney mGFR/BSA (mL/min/m2) | 32.34 ± 5.56 | 32.36 ± 5.39 | 0.974 |
| Age at kidney donation (years) | 43.90 ± 11.91 | 43.56 ± 12.32 | 0.694 |
| Sex (female) | 282/509 (55.40%) | 189/326 (57.98%) | 0.465 |
| BMI (kg/m2) | 23.81 ± 3.24 | 24.08 ± 3.23 | 0.236 |
| Baseline eGFR (CKD-EPI) (mL/min/1.73m2) | 99.97 ± 14.01 | 100.07 ± 13.87 | 0.926 |
| eGFR (CKD-EPI) at 1 month (mL/min/1.73m2) | 65.82 ± 12.74 | 65.97 ± 14.10 | 0.871 |
| eGFR (CKD-EPI) at 6 months (mL/min/1.73m2) | 68.97 ± 13.82 | 68.78 ± 14.46 | 0.847 |
BMI body mass index, BSA body surface area, CT computed tomography, eGFR estimated glomerular filtration rate, mGFR measured glomerular filtration rate.
Figure 1Correlations and agreement of baseline measures. (a) Correlation of baseline eGFR with total kidney volume/BSA. (b) Correlation of baseline eGFR with total kidney mGFR/BSA. (c) Scatter plot showing correlation of DTPA% with Vol% of remaining kidney. White fields represent concordant pairs (n = 509, 61%) and grey fields represent discordant pairs (n = 326, 39%). (d) Bland–Altman plot for agreement between DTPA% and Vol% of remaining kidney. Dotted line indicates the mean value of differences (y = 1.76) and dashed line indicates 95% CI for difference score data set (± 1.96*SD). BSA body surface area, CI confidence interval, DTPA diethylenetriamine penta-acetic acid, eGFR estimated glomerular filtration rate, mGFR measured glomerular filtration rate, SD standard deviation.
Figure 2Change of eGFR after kidney donation. (a) eGFR (mean ± SD) change over time in the total cohort group. Baseline eGFR is total eGFR from both kidneys. (b) eGFR (estimated marginal mean ± SE) over time in the CT volumetry preferred group (solid line) and nuclear renography preferred group (dotted line). Estimated marginal means are derived from linear mixed model. Baseline eGFR is SKF of the remaining kidney. CT computed tomography, eGFR estimated glomerular filtration rate, SD standard deviation, SE standard error, SKF split kidney function.
Correlation and multivariable linear regression analyses of post-donation eGFR with SKF (Vol% and DTPA%).
| (a) Total cohort | Correlation | Multivariable linear regression | |||||
|---|---|---|---|---|---|---|---|
| eGFR | Split kidney function | Pearson’s r | P value | β coefficient | P value | Relative importance | Adjusted R2 |
| At 1 month (n = 835) | SKF(Vol%) | 0.744 | < 0.001 | 0.402 | < 0.001 | 38.28% | 0.605 |
| SKF(DTPA%) | 0.728 | < 0.001 | 0.242 | < 0.001 | 35.46% | ||
| At 6 months (n = 835) | SKF(Vol%) | 0.765 | < 0.001 | 0.448 | < 0.001 | 39.56% | 0.627 |
| SKF(DTPA%) | 0.743 | < 0.001 | 0.214 | < 0.001 | 35.50% | ||
| At > 1 year (n = 641) | SKF(Vol%) | 0.722 | < 0.001 | 0.472 | < 0.001 | 40.59% | 0.554 |
| SKF(DTPA%) | 0.692 | < 0.001 | 0.160 | 0.015 | 34.71% | ||
Covariables for multivariable linear regression analyses: donor age, sex, BMI
BMI body mass index, CT computed tomography, DTPA diethylenetriamine penta-acetic acid, eGFR estimated glomerular filtration rate.
A Linear mixed-effect model for analyzing interaction of group and time with eGFR as the dependent variable.
| Estimate | SE | 95% CI | P value | ||
|---|---|---|---|---|---|
| Intercept | 79.60 | 4.39 | 70.96–88.24 | < 0.001 | |
| Age | − 0.56 | 0.04 | − 0.64–− 0.48 | < 0.001 | |
| Sex (female) | 5.40 | 1.01 | 3.40–7.39 | < 0.001 | |
| BMI | − 0.47 | 0.15 | − 0.77–− 0.17 | 0.002 | |
| 0.030 | |||||
| CT volumetry Preferred group | 0.07 | 1.44 | − 2.77–2.90 | 0.963 | |
| Nuclear renography Preferred group | Reference | ||||
| Time-points | < 0.001 | ||||
| Baseline | Reference | ||||
| 1 month | 13.15 | 0.56 | 12.06–14.25 | < 0.001 | |
| 6 months | 15.91 | 0.62 | 14.70–17.12 | < 0.001 | |
| > 1 year | 17.12 | 0.68 | 15.78–18.45 | < 0.001 | |
| Group × time-points | 0.004 | ||||
| CT volumetry preferred group | Baseline | Reference | |||
| 1 month | 2.24 | 1.24 | − 0.19–4.68 | 0.071 | |
| 6 months | 2.47 | 1.37 | − 0.21–5.16 | 0.071 | |
| > 1 year | 5.58 | 1.54 | 2.56–8.61 | < 0.001 | |
| Nuclear renography preferred group | Baseline | Reference | |||
| 1 month | Reference | ||||
| 6 months | Reference | ||||
| > 1 year | Reference | ||||
BMI body mass index, CI confidence interval, CT computed tomography, eGFR estimated glomerular filtration rate, SE standardized error.
Figure 3Flow chart showing donor selection in this study. CT computed tomography, LDKT living donor kidney transplantation.